Article: Following Claritin's Lead, Second-Generation Antihistamines Switching to Over-the-Counter Status Drive the Allergic Rhinitis Prescription Drug Market into a Downward Spiral.

Switches from Prescription to OTC Will Have Less of a Dramatic Impact in Europe, According to a New Study from Decision Resources

WALTHAM, Mass., June 20 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that the anticipated switch of second-generation antihistamines from prescription to over-the-counter (OTC) status in each of the seven major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will lead to increases in the number of patients opting to self medicate with nonprescription therapies rather than present to a physician ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!